+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Spark Therapeutics Inc (ONCE) - Financial and Strategic SWOT Analysis Review

  • ID: 4282011
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


Spark Therapeutics Inc (Spark) is a clinical-stage gene therapy company which provides gene therapies for inherited retinal diseases (IRDs), neurodegenerative diseases, as well as liver diseases. Its pipeline products include SPK-RPE65, SPK-CHM, rhonova, LHON, SPK-FIX, SPK-FVIII and SPK-TPP1. The company’s gene therapy vectors used in its programs are engineered using adeno-associated virus. Spark’s SPK-RPE65 is intentended to cure rare blinding conditions caused by mutations in the RPE65 gene. The company develops gene therapy products for the treatment of debilitating genetic diseases such as inherited retinal dystrophies, hematologic disorders and neurodegenerative diseases. It collaborates with pharma and biotech companies for its research and development activities. Spark is headquartered in Philadelphia, Pennsylvania, the US.

Spark Therapeutics Inc Key Recent Developments

Feb 20, 2018: Spark Therapeutics Reports 2017 Financial Results and Recent Business Progress
Jan 04, 2018: Spark Therapeutics Announces Addition of Robert J. Perez to Board of Directors
Nov 07, 2017: Spark Therapeutics Reports Third Quarter 2017 Financial Results and Recent Business Progress
Sep 25, 2017: Spark Therapeutics Further Expands Gene Therapy Expertise with Appointment of Federico Mingozzi, Ph.D., as Chief Scientific Officer
Aug 11, 2017: Spark Therapeutics Recognized as One of Philadelphia’s “Best Places to Work” by the Philadelphia Business Journal

This comprehensive SWOT profile of Spark Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Spark Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • Spark Therapeutics Inc - Key Information
  • Spark Therapeutics Inc - Overview
  • Spark Therapeutics Inc - Key Employees
  • Spark Therapeutics Inc - Key Employee Biographies
  • Spark Therapeutics Inc - Key Operational Heads
  • Spark Therapeutics Inc - Major Products and Services
  • Spark Therapeutics Inc - History
  • Spark Therapeutics Inc - Company Statement
  • Spark Therapeutics Inc - Locations And Subsidiaries
  • Spark Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Spark Therapeutics Inc - Business Description
  • Spark Therapeutics Inc - Corporate Strategy
  • Spark Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Spark Therapeutics Inc - Strengths
  • Spark Therapeutics Inc - Weaknesses
  • Spark Therapeutics Inc - Opportunities
  • Spark Therapeutics Inc - Threats
  • Spark Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Spark Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Spark Therapeutics Inc, Key Information
  • Spark Therapeutics Inc, Key Ratios
  • Spark Therapeutics Inc, Share Data
  • Spark Therapeutics Inc, Major Products and Services
  • Spark Therapeutics Inc, History
  • Spark Therapeutics Inc, Key Employees
  • Spark Therapeutics Inc, Key Employee Biographies
  • Spark Therapeutics Inc, Key Operational Heads
  • Spark Therapeutics Inc, Other Locations
  • Spark Therapeutics Inc, Subsidiaries
  • Spark Therapeutics Inc, Key Manufacturing facilities
  • Spark Therapeutics Inc, Key Competitors
  • Spark Therapeutics Inc, SWOT Analysis
  • Spark Therapeutics Inc, Ratios based on current share price
  • Spark Therapeutics Inc, Annual Ratios
  • Spark Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Spark Therapeutics Inc, Performance Chart
  • Spark Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown